June 5-8, 2023
BIO International Convention, Boston, MA
June 2-6, 2023
2023 ASCO Annual Meeting, Chicago, IL
May 23-24, 2023
Alliance Global Partners' Virtual Healthcare Conference
May 20-24, 2023
CYTO 2023, Montreal, Quebec, Canada - Sandra Ortega-Francisco, Ph.D., Department of Hematology and Hematopoietic Cell Transplantation and Hematologic Malignancies Research Institute, City of Hope, participated in a poster presentation titled, “Induction of multi-antigen specific T cell responses by a synthetic MVA-SARS-CoV-2 vaccine in patients with hematological malignancies.”
May 20-24, 2023
CYTO 2023, Montreal, Quebec, Canada - Sandra Ortega-Francisco, Ph.D., Department of Hematology and Hematopoietic Cell Transplantation and Hematologic Malignancies Research Institute, City of Hope, participated in a poster presentation titled, “Induction of multi-antigen specific T cell responses by a synthetic MVA-SARS-CoV-2 vaccine in patients with hematological malignancies.”
May 4, 2023
GeoVax First Quarter Earnings Call - webcast
April 30 - May 2, 2023
4th Symposium on Infectious Diseases in the Immunocompromised Host, Seattle, WA
April 1-4, 2023
World Vaccine Congress, Washington, DC - Dr. Don Diamond, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope delivered presentation titled “COVID-19 Vaccine CM04S1; A Superior Viral Platform Alternative for Eliciting Durable T Cell Responses in Immunocompromised Hematologic Malignancy Patients”
Dr. Jason Comer, Associate Professor, Sealy Institute for Vaccine Sciences, University of Texas Medical Branch (UTMB), delivered presentation titled “Preclinical Capabilities at the University of Texas Medical Branch: Evaluating Candidate Vaccines and Immunotherapeutics against Sudan Ebola Virus,”
March 23, 2023
GeoVax 2022 Earnings - webcast
February 6-9, 2023
BIO CEO & Investor Conference - New York, NY
January 9 - 12, 2023
Biotech Showcase, San Francisco, CA - webcast